MANNKIND CORP Warrants and Rights Outstanding
MANNKIND CORP (MNKD) had Warrants and Rights Outstanding of $7.40 million as of 2016-12-31, per its 10-K filed 2018-02-27.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2018-02-27
- 2016-12-31: Warrants and Rights Outstanding $7.40M.
- 2013-06-30: Warrants and Rights Outstanding $64.60M.
- 2012-02-29: Warrants and Rights Outstanding $47.30M.
- 2012-02-28: Warrants and Rights Outstanding $47.30M.
| Period end | Warrants and Rights Outstanding |
|---|---|
| 2016-12-31 | $7.40M 10-K · filed 2018-02-27 |
| 2013-06-30 | $64.60M 10-Q · filed 2013-08-09 |
| 2012-02-29 | $47.30M 10-Q · filed 2013-11-12 |
| 2012-02-28 | $47.30M 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |